Medicare Enrolled

Dr. Daniel Mascarenhas, MD

Cardiovascular Disease · Phillipsburg, NJ
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
Low-engagement
1000 COVENTRY DR, Phillipsburg, NJ 08865
9088593800
In practice since 2006 (19 years)
NPI: 1568558906 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mascarenhas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mascarenhas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mascarenhas

Dr. Daniel Mascarenhas is a cardiovascular disease specialist in Phillipsburg, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mascarenhas performed 2,850 Medicare services across 1,042 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mascarenhas received a total of $4,459 from 30 pharmaceutical and/or device companies across 201 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mascarenhas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 46% volume in NJ $4,459 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,850
Medicare services
Top 46% in NJ for cardiovascular disease
1,042
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~150 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Remote monitoring of implantable heart rhythm device
Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days.
689 $33 $100
Remote cardiac rhythm monitor evaluation, up to 30 days
Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days.
608 $21 $65
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
481 $70 $120
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
170 $99 $165
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
146 $173 $982
Remote pacemaker/defibrillator monitoring, 90 days
Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check.
122 $18 $85
Remote pacemaker monitoring, 90 days
Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart.
105 $22 $70
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
97 $12 $60
Regadenoson injection (Lexiscan) for heart stress test
An injection of regadenoson, a medication used to stress the heart during diagnostic testing.
97 $45 $64
Technetium Tc-99m sestamibi diagnostic injection
A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies.
48 $96 $128
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review.
47 $54 $250
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
46 $407 $950
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
45 $153 $230
30-day continuous ECG with patient-triggered event transmission and review
This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report.
40 $784 $1,400
Continuous ECG monitoring, up to 30 days
Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results.
38 $22 $100
Insertion of implantable heart rhythm monitor
A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit.
36 $4,095 $8,500
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
20 $119 $225
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
15 $76 $147
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.1% high complexity
8.4% medium
78.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,459
Total received (2018-2024)
Avg $637/year across 7 years
Top 40% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
201
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,394 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$66 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$212
2023
$1,699
2022
$369
2021
$546
2020
$532
2019
$559
2018
$542

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$76
Edwards Lifesciences Corporation
$74
Medline Industries LP
$19
Novartis Pharmaceuticals Corporation
$15
E.R. Squibb & Sons, L.L.C.
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 80.0% of 2024 payments
All-time payments by company (2018-2024) ›
Globus Medical, Inc.
$913
E.R. Squibb & Sons, L.L.C.
$714
Stryker Corporation
$561
Boehringer Ingelheim Pharmaceuticals, Inc.
$343
PFIZER INC.
$281
Edwards Lifesciences Corporation
$260
Abbott Laboratories
$243
AstraZeneca Pharmaceuticals LP
$200
Janssen Pharmaceuticals, Inc
$144
BOSTON SCIENTIFIC CORPORATION
$141
BIOTRONIK INC.
$125
Amgen Inc.
$85
Novartis Pharmaceuticals Corporation
$73
Amarin Pharma Inc.
$52
SANOFI-AVENTIS U.S. LLC
$45
Terumo Medical Corporation
$34
AtriCure, Inc.
$29
Kowa Pharmaceuticals America, Inc.
$25
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$22
InfoBionic, Inc
$22
MEDLINE INDUSTRIES LP
$20
Medline Industries LP
$19
ABIOMED
$18
Kiniksa Pharmaceuticals, Ltd.
$16
Medtronic Vascular, Inc.
$14
GE Healthcare
$14
Boston Scientific Corporation
$14
Astellas Pharma US Inc
$12
ARBOR PHARMACEUTICALS, INC.
$11
Esperion Therapeutics, Inc.
$11
Top 3 companies account for 49.1% of all-time payments
Associated products mentioned in payments ›
Ankle Fracture System · Arcalyst · BIOMONITOR · BRILINTA · BioMonitor · CAMZYOS · CHANTIX · Clavicular Fracture Fixation · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · Edarbi · Edora · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Epi-Sense Guided Coagulation System with VisiTrax · GAMMA · GENERAL THERAPIES · Glidesheath · ICDs · Impella · JARDIANCE · LEQVIO · LEXISCAN · LifeVest · Livalo · MAKO · MEDLINE · MULTAQ · Merlin Connectivity and Remote · MetaCross · MoMe Device · Models · NEXLETOL · PRADAXA · RESONATE · Repatha · Reveal LINQ · Rivacor 7 DR-T · SAPIEN 3 Ultra RESILIA · Solia · Vascepa · XARELTO · Xience Alpine cornary stent system
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease specialist in Phillipsburg?
Compare cardiologists in the Phillipsburg area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
148
Per 100K population
134.3
County median income
$99,596
Nearest hospital
ST LUKE'S WARREN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mascarenhas is a remote monitoring specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mascarenhas experienced with remote monitoring of implantable heart rhythm device?
Based on Medicare claims data, Dr. Mascarenhas performed 689 remote monitoring of implantable heart rhythm device services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mascarenhas receive payments from pharmaceutical companies?
Yes. Dr. Mascarenhas received a total of $4,459 from 30 companies across 201 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mascarenhas's costs compare to other cardiologists in Phillipsburg?
Dr. Mascarenhas's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mascarenhas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →